Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lisa Nolan Joins Rexahn Pharmaceuticals

Executive Summary

Cancer focused Rexahn Pharmaceuticals Inc. has appointed Lisa Nolan to the newly created position of chief business officer (CBO). She previously held similar positions at Relmada Therapeutics and Topigen Pharmaceuticals, where she was CBO, and SkyePharma, where she was vice president, global business development and strategic marketing. Nolan has also been managing director of Nolex Advisors LLC.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC096906

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel